The global L–Histidine market is projected to grow at a CAGR of around 5% during the forecast period. L-Histidine is one of the 23 proteinogenic amino acids and is an essential amino acid. It is involved in protein synthesis and influences several metabolic processes in the body. It is a necessary component in the recovery from disease as well as during development. An unbalanced diet and a stressful lifestyle can cause L-histidine deficiency, which can cause development problems or rheumatoid arthritis in adults.
Type 1 diabetes, multiple sclerosis, rheumatoid arthritis, lupus, Crohn's disease, psoriasis, and scleroderma impact almost 4% of the global population. In the US, autoimmune disorders are the third most frequent cause of chronic illness. Although many autoimmune illnesses are uncommon, the National Institutes of Health (NIH) estimates that they affect between 5% and 8% of the US population. Autoimmune disorders are becoming more common for unclear reasons. The growing prevalence of autoimmune illnesses and chronic diseases contribute to the market growth.
Furthermore, rising demand for cost-effective treatments in developing nations, as well as an increase in the approval of novel medicines for the treatment of chronic illnesses, provide market development opportunities. For instance, in March 2021, Maypro announced the launch of NeuroHD for neuro-cognitive assistance. The ingredient is a non-synthetic histidine dipeptide complex obtained from a natural source.
Market Coverage
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
L - Histidine Market Report
By Product
By Region
North America
Europe
Asia-Pacific
Rest of the World
REQUEST FOR TABLE
OF CONTENT